Valuation: Elekta AB (publ)

Market Cap 1.84TCr 189.51Cr 166.16Cr 153.16Cr 143.39Cr 268.88Cr 18TCr 274.46Cr 712.32Cr 8.84TCr 711.6Cr 696.06Cr 31TCr P/E 2026
-39.2x
P/E 2027 * 12.9x
Enterprise Value 2.24TCr 230.89Cr 202.45Cr 186.61Cr 174.7Cr 327.6Cr 22TCr 334.4Cr 867.88Cr 11TCr 867Cr 848.07Cr 37TCr EV / Sales 2026
1.41x
EV / Sales 2027 * 1.26x
Free-Float
94.03%
Yield 2026
4.51%
Yield 2027 * 5.24%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 189.51Cr
+1.44%+10.42%+25.66%+0.56% 19TCr
+1.25%-0.51%-24.17%+21.54% 14TCr
+1.75%+10.74%-1.31%-16.43% 14TCr
+0.07%-2.34%-58.48%-17.25% 6.57TCr
+1.18%+3.91%+16.07%+0.38% 5.23TCr
-0.31%-0.03%-27.04%-32.66% 4.35TCr
+0.37%+7.04%+14.13%+16.88% 3.84TCr
-0.66%+5.34%+6.24%+45.44% 3.68TCr
+1.26%+6.77%-11.59%-14.81% 2.99TCr
Average +0.74%+4.59%-6.72%+0.40% 8.22TCr
Weighted average by Cap. +1.05%+5.58%-3.40%+0.34%

Financials

2026 2027 *
Net sales 1.7TCr 174.67Cr 153.15Cr 141.17Cr 132.16Cr 247.82Cr 16TCr 252.97Cr 656.54Cr 8.14TCr 655.87Cr 641.55Cr 28TCr 1.74TCr 178.96Cr 156.92Cr 144.64Cr 135.41Cr 253.92Cr 17TCr 259.19Cr 672.69Cr 8.34TCr 672.01Cr 657.33Cr 29TCr
Net income 85Cr 8.75Cr 7.67Cr 7.07Cr 6.62Cr 12Cr 825.05Cr 13Cr 33Cr 407.76Cr 33Cr 32Cr 1.41TCr 142.61Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.38TCr 21Cr 55Cr 684.45Cr 55Cr 54Cr 2.37TCr
Net Debt 402.03Cr 41Cr 36Cr 33Cr 31Cr 59Cr 3.9TCr 60Cr 155.56Cr 1.93TCr 155.4Cr 152.01Cr 6.69TCr 348.19Cr 36Cr 31Cr 29Cr 27Cr 51Cr 3.38TCr 52Cr 134.73Cr 1.67TCr 134.59Cr 131.66Cr 5.79TCr
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-